Updates in Osteosarcoma

JN Bryan - Veterinary Clinics: Small Animal Practice, 2024 - vetsmall.theclinics.com
Clinical care of osteosarcoma (OSA) in companion dogs has been relatively static during the
past 20 years. The disease of OSA can be described as one of “life and limb.” The limb pain …

[HTML][HTML] Viral shedding in mice following intravenous adenovirus injection: impact on biosafety classification

CJ LaRocca, KL Jacobsen, K Inoko, SO Zakharkin… - Viruses, 2023 - mdpi.com
There have been numerous advances in gene therapy and oncolytic virotherapy in recent
years, especially with respect to cutting-edge animal models to test these novel therapeutics …

[HTML][HTML] Tumor-homing of mesenchymal stem cells infected with oncolytic virus in a canine patient

P Delgado-Bonet, BD Tomeo-Martín, G Ortiz-Díez… - Veterinary …, 2022 - mdpi.com
Intravenous administration of oncolytic adenovirus (OAds) can be challenging, although
various vehicles for the delivery of the virus to the tumor have been described. The efficacy …

Il potenziale terapeutico delle cellule stromali mesenchimali nella terapia dei tumori: uno strumento innovativo per la medicina veterinaria?

V Arosio - 2023 - repository.unipr.it
Applicazioni terapeutiche delle cellule stromali mesenchimali nella terapia oncologica. Le
MSCs possono esser usate come veicolo di virus oncolitici o di fattori inducente arresto …

[HTML][HTML] Combination Therapy Using Adenovirus Delivered Immune Adjuvants To Improve CAR T Cells In Solid Tumors

CB Driscoll - 2021 - search.proquest.com
CAR T cell therapies have struggled in solid tumors to recapitulate the clinical results
obtained against leukemia and lymphomas. Combination therapy is needed to overcome …